Latest Breaking News On - Christine regan lindenboom - Page 5 : comparemela.com

Alnylam Announces Updates to its Board of Directors

Alnylam Announces Updates to its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomNew yorkUnited statesChristine regan lindenboomMichaelw bonneyJosh brodskyAmyw schulmanRayze bioPiyush sharmaIntervenn bioYvonne greenstreetCarolyn bertozziRoyal society united kingdomStanford school of humanitiesSenior lecturer at harvard business schoolAlnylam pharmaceuticals inc

Alnylam to Webcast Presentation at 41st Annual J P Morgan Healthcare Conference

Alnylam to Webcast Presentation at 41st Annual J P Morgan Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomSan franciscoUnited statesChristine regan lindenboomJosh brodskyAlnylam pharmaceuticalsAlnylam pharmaceuticals nasdaqAlnylam pharmaceuticals incHealthcare conferenceNobel prize winning

Alnylam Submits Supplemental New Drug Application (sNDA) to U S Food and Drug Administration (FDA) for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR Amyloidosis

Alnylam Submits Supplemental New Drug Application (sNDA) to U S Food and Drug Administration (FDA) for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesChristine regan lindenboomJosh brodskyRenan denoncourtInternational symposium on amyloidosisDrug administrationAlnylam pharmaceuticals incHealth statusExchange commissionAlnylam pharmaceuticalsEuropean unionFunctional capacityLife comparedNew drug applicationVice president

Alnylam Announces FDA Approval of Supplemental New Drug Application for OXLUMO® (lumasiran) in Advanced Primary Hyperoxaluria Type 1

Alnylam Announces FDA Approval of Supplemental New Drug Application for OXLUMO® (lumasiran) in Advanced Primary Hyperoxaluria Type 1
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesChristine regan lindenboomJorge capapeyJosh brodskyKim hollanderHyperoxaluria foundationGlobal rare disease lead at alnylam pharmaceuticalsDrug administrationAlnylam pharmaceuticals incExchange commissionAlnylam pharmaceuticalsEuropean medicines agencyCommittee for medicinal products human usePrimary hyperoxaluria typeLower urinary

Alnylam Pharma (ALNY) Announces FDA Approval of Supplemental New Drug Application for OXLUMO

Alnylam Pharma (ALNY) Announces FDA Approval of Supplemental New Drug Application for OXLUMO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.